Keeping up with the genomes: scaling genomic variant interpretation

Heidi L Rehm^{1

2

3}, Douglas M Fowler^{4

5

6}

Affiliations

¹ Center for Genomic Medicine, Massachusetts General Hospital, Cambridge Street, Boston, MA, 02114, USA. hrehm@mgh.harvard.edu.
² Medical and Population Genetics, Broad Institute of MIT and Harvard, Main Street, Cambridge, MA, 02142, USA. hrehm@mgh.harvard.edu.
³ Department of Pathology, Harvard Medical School, Shattuck Street, Boston, MA, 02115, USA. hrehm@mgh.harvard.edu.
⁴ Department of Genome Sciences, University of Washington, 15th Avenue NE, Seattle, WA, 98195-5065, USA. dfowler@uw.edu.
⁵ Canadian Institute for Advanced Research, University Avenue, Toronto, ON, M5G 1M1, Canada. dfowler@uw.edu.
⁶ Department of Bioengineering, University of Washington, 15th Avenue NE, Seattle, WA, 98195-5061, USA. dfowler@uw.edu.

Editorial

Heidi L Rehm et al. Genome Med. 2019.

. 2019 Dec 31;12(1):5.

doi: 10.1186/s13073-019-0700-4.

Heidi L Rehm^{1

2

3}, Douglas M Fowler^{4

5

6}

¹ Center for Genomic Medicine, Massachusetts General Hospital, Cambridge Street, Boston, MA, 02114, USA. hrehm@mgh.harvard.edu.
² Medical and Population Genetics, Broad Institute of MIT and Harvard, Main Street, Cambridge, MA, 02142, USA. hrehm@mgh.harvard.edu.
³ Department of Pathology, Harvard Medical School, Shattuck Street, Boston, MA, 02115, USA. hrehm@mgh.harvard.edu.
⁴ Department of Genome Sciences, University of Washington, 15th Avenue NE, Seattle, WA, 98195-5065, USA. dfowler@uw.edu.
⁵ Canadian Institute for Advanced Research, University Avenue, Toronto, ON, M5G 1M1, Canada. dfowler@uw.edu.
⁶ Department of Bioengineering, University of Washington, 15th Avenue NE, Seattle, WA, 98195-5061, USA. dfowler@uw.edu.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

1. Lindstrand A, Eisfeldt J, Pettersson M, Carvalho CMB, Kvarnung M, Grigelioniene G, et al. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Genome Med. 2019;11:68. doi: 10.1186/s13073-019-0675-1. - DOI - PMC - PubMed
1. Abul-Husn NS, Soper ER, Odgis JA, Cullina S, Bobo D, Moscati A, et al. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med. 2019. 10.1186/s13073-019-0691-1 - PMC - PubMed
1. Brnich SA, Abou Tayoun AN, Couch FJ, Cutting G, Greenblatt MS, Heinen CD, et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 2019. 10.1186/s13073-019-0690-2 - PMC - PubMed
1. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed
1. Gelman et al. Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation. Genome Med. 2019. 10.1186/s13073-019-0698-7 - PMC - PubMed